Skip to content
Screener

GRAIL, Inc. GRAL Price / sales

Price / sales at other companies

Abbott logo
AbbottABT
3.4×-2.2×
Guardant Health logo
Guardant HealthGH
11.2×+4.4×
Natera, Inc. logo
Natera, Inc.NTRA
14.4×+2.4×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
7.3×-5.2×
Myriad Genetics logo
Myriad GeneticsMYGN
0.5×-0.5×
Personalis, Inc. logo
Personalis, Inc.PSNL
10.3×+6.7×

Other financials

Income statement

See full
Revenue$44.7M+25.7%
Operating income-$173.8M-9.4%
Net income-$110.2M+3.3%
EPS (diluted)-$2.56+19.5%

Balance sheet

See full
Cash & equivalents$62.6M-52.1%
Total debt$91.3M+46.9%
Total equity$2.5B+9.9%
Total assets$2.8B+5.2%

Cash flow

See full
Operating cash flow-$80.7M-4.9%
CapEx$432.0K+17.1%
Free cash flow-$81.2M-4.9%

Valuation

See full
Market cap$2.72B+129%
Enterprise value$2.75B+145%

Profitability

See full
Operating margin-338.4%-74.4pp
Net margin-236.9%-52.1pp
FCF margin-179.2%-46.7pp

Returns & leverage

See full
Return on equity-16.1%-1.3pp
Debt / equity0.0×
Current ratio10.9×+1.7×

Where this comes from

Calculated from GRAIL, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: GRAIL, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054307

FAQ

What is GRAIL, Inc.'s price / sales?
GRAIL, Inc. (GRAL) reported price / sales of 17.7× in Q2 2026.
How has GRAIL, Inc.'s price / sales changed year-over-year?
GRAIL, Inc.'s price / sales increased by 50.6% year-over-year, from 11.8× to 17.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about GRAIL, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude